Nathan A. Berger, MD - Publications

Affiliations: 
Medicine Case Western Reserve University, Cleveland Heights, OH, United States 
Website:
http://casemed.case.edu/cshs/director.cfm

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ligibel JA, Schmitz KH, Berger NA. Sarcopenia in aging, obesity, and cancer. Translational Cancer Research. 9: 5760-5771. PMID 33163373 DOI: 10.21037/Tcr-2019-Eaoc-05  0.354
2020 Bruno DS, Berger NA. Impact of bariatric surgery on cancer risk reduction. Annals of Translational Medicine. 8: S13. PMID 32309417 DOI: 10.21037/Atm.2019.09.26  0.344
2020 Owusu C, Nock N, Hergenroeder PF, Austin K, Bennett B, Cerne S, Moore HCF, Petkac J, Schluchter MD, SCHMITZ KH, Webb-Hooper M, Wimbley L, Coccia S, Nagy C, Berger NA. Improve, a community-based exercise intervention versus support group to improve functional and health outcomes among older African American and non-hispanic white breast cancer survivors from diverse socioeconomic backgrounds: Recruitment strategies and baseline characteristics. Journal of Clinical Oncology. 38: e24052-e24052. DOI: 10.1200/Jco.2020.38.15_Suppl.E24052  0.321
2019 Owusu C, Nock N, Hergenroeder P, Austin K, Bennett B, Cerne S, Moore HCF, Petkac J, Schluchter MD, SCHMITZ KH, Atkins L, Asagba O, Wimbley L, Berger NA. Improve: A community-based physical activity intervention to improve functional and health outcomes in older breast cancer survivors: Rationale, design, and methods. Journal of Clinical Oncology. 37: TPS11629-TPS11629. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps11629  0.326
2018 Owusu C, Schluchter M, Koroukian SM, Schmitz KH, Berger NA. Black-white disparity in physical performance among older women with newly diagnosed non-metastatic breast cancer: Exploring the role of inflammation and physical activity. Journal of Geriatric Oncology. PMID 29699938 DOI: 10.1016/J.Jgo.2018.04.004  0.314
2018 Berger NA. Young Adult Cancer: Influence of the Obesity Pandemic. Obesity (Silver Spring, Md.). 26: 641-650. PMID 29570247 DOI: 10.1002/Oby.22137  0.317
2018 Berger NA, Scacheri PC. Targeting Epigenetics to Prevent Obesity Promoted Cancers. Cancer Prevention Research (Philadelphia, Pa.). PMID 29476043 DOI: 10.1158/1940-6207.Capr-18-0043  0.344
2018 Owusu C, Antognoli E, Nock N, Hergenroeder P, Austin K, Bennet E, Berger NA, Cerne S, Foraker K, Heine K, Heyman E, Moore H, Petkac J, Schluchter M, Schmitz KH, et al. Perspective of older African-American and Non-Hispanic white breast cancer survivors from diverse socioeconomic backgrounds toward physical activity: A qualitative study. Journal of Geriatric Oncology. PMID 29306608 DOI: 10.1016/J.Jgo.2017.12.003  0.318
2017 Warner DF, Schiltz NK, Stange KC, Given CW, Owusu C, Berger NA, Koroukian SM. Complex multimorbidity and health outcomes in older adult cancer survivors. Family Medicine and Community Health. 5: 129-138. PMID 30956969 DOI: 10.15212/Fmch.2017.0127  0.307
2017 Berger NA. Crown-Like Structures in Breast Adipose Tissue from Normal Weight Women: Enormous Impact. Cancer Prevention Research (Philadelphia, Pa.). PMID 28274935 DOI: 10.1158/1940-6207.Capr-17-0062  0.336
2016 Owusu C, Margevicius S, Schluchter M, Koroukian SM, Schmitz KH, Berger NA. Vulnerable elders survey and socioeconomic status predict functional decline and death among older women with newly diagnosed nonmetastatic breast cancer. Cancer. PMID 27348765 DOI: 10.1002/Cncr.30046  0.317
2015 Berger NA. A time to stop, a time to start: high-dose chemotherapy in overweight and obese patients. Bone Marrow Transplantation. 50: 617-8. PMID 25730189 DOI: 10.1038/Bmt.2015.26  0.306
2015 Sanchis-Gomar F, Lucia A, Yvert T, Ruiz-Casado A, Pareja-Galeano H, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G, Bouchard C, Berger NA. Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. Cancer Prevention Research (Philadelphia, Pa.). 8: 105-10. PMID 25416409 DOI: 10.1158/1940-6207.Capr-14-0320  0.352
2015 Bruno DS, White PS, Thompson CL, Adebisi M, Berger NA. Lipid profile and breast cancer characteristics: A retrospective correlational study. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E12659  0.328
2014 Thompson CL, Owusu C, Nock NL, Li L, Berger NA. Race, age, and obesity disparities in adult physical activity levels in breast cancer patients and controls. Frontiers in Public Health. 2: 150. PMID 25285306 DOI: 10.3389/Fpubh.2014.00150  0.349
2014 Berger NA. Obesity and cancer pathogenesis. Annals of the New York Academy of Sciences. 1311: 57-76. PMID 24725147 DOI: 10.1111/Nyas.12416  0.341
2014 Berger NA. Obesity-associated gastrointestinal tract cancer: from beginning to end. Cancer. 120: 935-9. PMID 24448723 DOI: 10.1002/Cncr.28534  0.322
2014 Koroukian SM, Schiltz NK, Warner D, Given CW, Owusu C, Schluchter MD, Berger NA. Multimorbidity and racial disparities in use of hospice by older patients dying from cancer. Journal of Clinical Oncology. 32: 9542-9542. DOI: 10.1200/Jco.2014.32.15_Suppl.9542  0.32
2013 Owusu C, Schluchter M, Koroukian SM, Mazhuvanchery S, Berger NA. Racial disparities in functional disability among older women with newly diagnosed nonmetastatic breast cancer. Cancer. 119: 3839-46. PMID 24114615 DOI: 10.1002/Cncr.28232  0.304
2013 Zheng Q, Banaszak L, Fracci S, Basali D, Dunlap SM, Hursting SD, Rich JN, Hjlemeland AB, Vasanji A, Berger NA, Lathia JD, Reizes O. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocrine-Related Cancer. 20: 797-808. PMID 24025407 DOI: 10.1530/Erc-13-0329  0.365
2013 Weiss BM, Vogl DT, Berger NA, Stadtmauer EA, Lazarus HM. Trimming the fat: obesity and hematopoietic cell transplantation. Bone Marrow Transplantation. 48: 1152-60. PMID 23103679 DOI: 10.1038/Bmt.2012.201  0.311
2013 Owusu C, Schluchter MD, Koroukian SM, Schmitz K, Berger NA. Black-white disparity in physical performance among older women with breast cancer: The role of physical activity and inflammation. Journal of Clinical Oncology. 31: 6525-6525. DOI: 10.1200/Jco.2013.31.15_Suppl.6525  0.319
2013 Doerner SK, Leung ES, Ko JS, Nadeau JH, Berger NA. Abstract 2859: Differential effects of specific dietary fat sources on inflammation and intestinal tumorigenesis. Cancer Research. 73: 2859-2859. DOI: 10.1158/1538-7445.Am2013-2859  0.312
2012 Meropol NJ, Berger NA. Colon cancer recurrence: insights from the interface between epidemiology, laboratory science, and clinical medicine. Journal of the National Cancer Institute. 104: 1697-8. PMID 23136359 DOI: 10.1093/Jnci/Djs454  0.381
2012 Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prevention Research (Philadelphia, Pa.). 5: 1260-72. PMID 23034147 DOI: 10.1158/1940-6207.Capr-12-0140  0.347
2012 Blake-Gumbs L, Chen Z, Thompson CL, Berger NA, Tucker TC, Li L. Adult BMI Change and Risk of Colon Cancer in Postmenopausal Women. Journal of Obesity. 2012: 857510. PMID 22848798 DOI: 10.1155/2012/857510  0.323
2012 Koroukian S, Bakaki P, Htoo P, Schluchter M, Owusu C, Berger N. In older adults with breast and colorectal cancer, multimorbidity, but not age, is associated with hospital admissions for chemotherapy-related adverse events Journal of Geriatric Oncology. 3: S53. DOI: 10.1016/J.Jgo.2012.10.037  0.305
2011 Owusu C, Schluchter MD, Koroukian SM, Berger NA. The trajectory of physical functioning during breast cancer treatment of older women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9129. PMID 28022422 DOI: 10.1200/Jco.2011.29.15_Suppl.9129  0.316
2011 Owusu C, Koroukian SM, Schluchter M, Bakaki P, Berger NA. Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments. Journal of Geriatric Oncology. 2: 121-129. PMID 21927633 DOI: 10.1016/J.Jgo.2010.12.002  0.315
2011 Zheng Q, Smith S, Zhu J, Downs-Kelly E, Hursting SD, Rich JN, Berger NA, Reizes O. Abstract 3327: Leptin receptors are expressed in breast cancer stem cells and leptin promotes their self-renewal and survival in mice Cancer Research. 71: 3327-3327. DOI: 10.1158/1538-7445.Am2011-3327  0.348
2010 Hursting SD, Berger NA. Energy balance, host-related factors, and cancer progression. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4058-65. PMID 20697088 DOI: 10.1200/Jco.2010.27.9935  0.334
2010 Owusu C, Schluchter MD, Koroukian SM, Bakaki P, Berger NA. Utility of the vulnerable elders survey for predicting sixth-month functional decline among older patients with newly diagnosed breast cancer. Journal of Clinical Oncology. 28: 598-598. DOI: 10.1200/Jco.2010.28.15_Suppl.598  0.311
2010 Ortiz‐Martinez AP, Thompson CL, Berger N, Li L. Abstract B112: Metabolic syndrome and risk of colon adenomas Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B112  0.333
2008 Nock NL, Thompson CL, Tucker TC, Berger NA, Li L. Associations between obesity and changes in adult BMI over time and colon cancer risk. Obesity (Silver Spring, Md.). 16: 1099-104. PMID 18356841 DOI: 10.1038/Oby.2008.42  0.334
2002 Hirota H, Gosky D, Berger NA, Chatterjee S. Interference with topoisomerase IIα potentiates melphalan cytotoxicity International Journal of Oncology. 20: 311-318. DOI: 10.3892/Ijo.20.2.311  0.328
1999 Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Biochemical and Biophysical Research Communications. 257: 361-8. PMID 10198218 DOI: 10.1006/Bbrc.1999.0472  0.348
1994 Ashwell JD, Berger NA, Cidlowski JA, Lane DP, Korsmeyer SJ. Coming to terms with death: apoptosis in cancer and immune development. Immunology Today. 15: 147-51. PMID 7911020 DOI: 10.1016/0167-5699(94)90309-3  0.303
1994 Chatterjee S, Berger NA. Growth-phase-dependent response to DNA damage in poly(ADP-ribose) polymerase deficient cell lines: basis for a new hypothesis describing the role of poly(ADP-ribose) polymerase in DNA replication and repair. Molecular and Cellular Biochemistry. 138: 61-9. PMID 7898477 DOI: 10.1007/Bf00928444  0.31
1994 Anderson RD, Berger NA. International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutation Research. 309: 109-42. PMID 7519727 DOI: 10.1016/0027-5107(94)90048-5  0.312
1992 Gordon NH, Crowe JP, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. American Journal of Epidemiology. 135: 609-18. PMID 1580237 DOI: 10.1093/Oxfordjournals.Aje.A116340  0.323
1992 Gerson SL, Berger NA, Arce C, Petzold SJ, Willson JK. Modulation of nitrosourea resistance in human colon cancer by O6-methylguanine. Biochemical Pharmacology. 43: 1101-7. PMID 1554383 DOI: 10.1016/0006-2952(92)90618-S  0.35
1991 Morris JB, Stellato TA, Guy BB, Gordon NH, Berger NA. A critical analysis of the largest reported mass fecal occult blood screening program in the United States. American Journal of Surgery. 161: 101-5; discussion 10. PMID 1987842 DOI: 10.1016/0002-9610(91)90368-N  0.301
1991 Chatterjee S, Cheng MF, Berger SJ, Berger NA. Alkylating agent hypersensitivity in poly(adenosine diphosphate-ribose) polymerase deficient cell lines. Cancer Communications. 3: 71-5. PMID 1900426 DOI: 10.3727/095535491820873551  0.309
1991 Berger NA. Oxidant-induced cytotoxicity: a challenge for metabolic modulation. American Journal of Respiratory Cell and Molecular Biology. 4: 1-3. PMID 1898851 DOI: 10.1165/Ajrcmb/4.1.1  0.314
1990 Chatterjee S, Cheng MF, Berger NA. Hypersensitivity to clinically useful alkylating agents and radiation in poly(ADP-ribose) polymerase-deficient cell lines. Cancer Communications. 2: 401-7. PMID 1702304 DOI: 10.3727/095535490820873958  0.326
1989 Chatterjee S, Cheng MF, Trivedi D, Petzold SJ, Berger NA. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Communications. 1: 389-94. PMID 2562007 DOI: 10.3727/095535489820875129  0.313
1988 Berger NA, Hirschler N. Therapeutic strategies for cancer chemotherapy based on metabolic consequences of DNA damage. Annals of the New York Academy of Sciences. 551: 415-8; discussion 41. PMID 3149880 DOI: 10.1111/J.1749-6632.1988.Tb22374.X  0.343
1987 Chatterjee S, Petzold SJ, Berger SJ, Berger NA. Strategy for selection of cell variants deficient in poly(ADP-ribose) polymerase. Experimental Cell Research. 172: 245-57. PMID 3115798 DOI: 10.1016/0014-4827(87)90384-3  0.316
1987 Berger NA, Berger SJ, Sudar DC, Distelhorst CW. Role of nicotinamide adenine dinucleotide and adenosine triphosphate in glucocorticoid-induced cytotoxicity in susceptible lymphoid cells. The Journal of Clinical Investigation. 79: 1558-63. PMID 3108318 DOI: 10.1172/Jci112989  0.326
1986 Berger NA. Cancer chemotherapy: new strategies for success. The Journal of Clinical Investigation. 78: 1131-5. PMID 3533996 DOI: 10.1172/Jci112692  0.324
1986 Das SK, Berger NA. Alterations in deoxynucleoside triphosphate metabolism in DNA damaged cells: identification and consequences of poly(ADP-ribose) polymerase dependent and independent processes. Biochemical and Biophysical Research Communications. 137: 1153-8. PMID 3089221 DOI: 10.1016/0006-291X(86)90346-3  0.311
1986 Berger SJ, Sudar DC, Berger NA. Metabolic consequences of DNA damage: DNA damage induces alterations in glucose metabolism by activation of poly (ADP-ribose) polymerase. Biochemical and Biophysical Research Communications. 134: 227-32. PMID 3080986 DOI: 10.1016/0006-291X(86)90551-6  0.311
1985 Berger NA, Berger SJ, Catino DM, Petzold SJ, Robins RK. Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy. The Journal of Clinical Investigation. 75: 702-9. PMID 3919063 DOI: 10.1172/Jci111750  0.323
1985 Gerson SL, Miller K, Berger NA. O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. The Journal of Clinical Investigation. 76: 2106-14. PMID 3878366 DOI: 10.1172/Jci112215  0.305
Show low-probability matches.